Kalin Katherine Bach 4
4 · SELLAS Life Sciences Group, Inc. · Filed Aug 16, 2022
Insider Transaction Report
Form 4
Kalin Katherine Bach
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-08-13+19,000→ 19,000 totalExercise: $3.10Exp: 2032-08-13→ Common Stock (19,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on August 13, 2023.